Form 4: Columbia Financial Inc. Executive Acquires Shares and Holds Stock Options
SEC Form 4 Filing
William Justin Jennings, EVP at Columbia Financial, reports acquisition of common stock through a stock-based deferral plan and holds various stock options and awards.
Summary
- On May 16, 2025, William Justin Jennings, an EVP at Columbia Financial, Inc. (CLBK), reported changes in beneficial ownership to the SEC.
- Jennings acquired common stock through a stock-based deferral plan at a price of $15.2 per share, totaling 49.3421 shares.
- Following the reported transaction, Jennings directly owns 11,754 shares of common stock.
- Jennings also indirectly owns shares through various plans including an ESOP (3,116 shares), SERP (608 shares), Stock Award II (7,795 shares), and Stock Award III (7,533 shares).
- Jennings holds stock options to buy 41,475 shares at $21.79 (fully vested), 5,715 shares at $16.49 (vesting starts 03/06/2025), and 13,051 shares at $16.23 (vesting starts 03/03/2026).
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of insider transactions. The acquisition of shares and holding of options can be seen as a positive sign, but it's not overwhelmingly bullish.
Positives
- The acquisition of shares through the stock-based deferral plan indicates Jennings' continued investment in the company's future.
Future Outlook
The document outlines future vesting dates for stock options and awards, contingent upon continued employment and, in some cases, achievement of performance-based criteria.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency regarding insider transactions. They are closely watched by investors to gauge management's sentiment and confidence in the company's prospects.
Comparison to Industry Standards
- Executive compensation packages often include a mix of salary, stock options, and stock awards to align management's interests with those of shareholders.
- Vesting schedules for stock options and awards are common, typically ranging from three to five years, to incentivize long-term performance.
- The specific terms of the equity incentive plan, such as vesting criteria and performance metrics, are tailored to the company's specific goals and industry practices.
- Comparing Columbia Financial's equity compensation practices to those of peer institutions like OceanFirst Financial Corp. or Investors Bancorp, Inc. would provide a more comprehensive assessment.
Stakeholder Impact
- The reported transactions provide transparency to shareholders regarding executive compensation and ownership.
Key Dates
| Date | Description |
|---|---|
| 03/21/2023 | Date of grant for fully vested stock options with an exercise price of $21.79. |
| 03/06/2025 | Commencement date for vesting of stock options with an exercise price of $16.49. |
| 03/06/2025 | Commencement date for vesting of 25% of Stock Awards II. |
| 03/03/2026 | Commencement date for vesting of stock options with an exercise price of $16.23. |
| 03/03/2028 | Vesting date for the remaining 75% of Stock Awards II, contingent upon achievement of performance-based criteria. |
| 03/06/2034 | Expiration date for stock options with an exercise price of $16.49. |
| 03/03/2035 | Expiration date for stock options with an exercise price of $16.23. |
| 05/16/2025 | Date of the reported transaction: acquisition of common stock through a stock-based deferral plan. |
| 05/20/2025 | Date of signature by Power of Attorney. |
Keywords
Form 4, beneficial ownership, stock options, stock awards, Columbia Financial, CLBK, Jennings, EVP, stock-based deferral plan, ESOP, SERP
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.